ARTICLE
25 October 2016

Prospectuses: ESMA Updates Q&A - October 2016

AO
A&O Shearman

Contributor

A&O Shearman was formed in 2024 via the merger of two historic firms, Allen & Overy and Shearman & Sterling. With nearly 4,000 lawyers globally, we are equally fluent in English law, U.S. law and the laws of the world’s most dynamic markets. This combination creates a new kind of law firm, one built to achieve unparalleled outcomes for our clients on their most complex, multijurisdictional matters – everywhere in the world. A firm that advises at the forefront of the forces changing the current of global business and that is unrivalled in its global strength. Our clients benefit from the collective experience of teams who work with many of the world’s most influential companies and institutions, and have a history of precedent-setting innovations. Together our lawyers advise more than a third of NYSE-listed businesses, a fifth of the NASDAQ and a notable proportion of the London Stock Exchange, the Euronext, Euronext Paris and the Tokyo and Hong Kong Stock Exchanges.
On 15 July 2016, the European Securities and Markets Authority ("ESMA") published an updated version of its Q&A to include two new questions.
European Union Corporate/Commercial Law

On 15 July 2016, the European Securities and Markets Authority ("ESMA") published an updated version of its Q&A to include two new questions. The first new question concerns the applicability of the requirements under Article 11(3) of Commission Delegated Regulation (EU) 2016/301. ESMA clarified that a new roadshow would not have to be organised in order to deliver an amended version of the information provided in the original, but the general requirement to amend the roadshow advertisement still applies. ESMA added it is the responsibility of the issuer, offeror or person asking for admission to trading to disseminate the amended version of the information by the most suitable means.

The second new question concerns how an issuer, offeror or person asking for admission to trading should proceed when a participant at a live presentation requests information about an alternative performance measure that is not included in the prospectus. ESMA clarified that such an issuer, offeror or person asking for admission to trading should decline to provide an answer, as otherwise there would be a breach of Article 12 of Commission Delegated Regulation (EU) 2016/301.

Version 25 of ESMA's Q&A on prospectuses can be accessed here:

https://www.esma.europa.eu/press-news/esma-news/esma-updates-its-qa-document-prospectus-related-issues-1

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More